Comparing the current results to its competitors, Alcon Inc reported Revenue increase in the 4 quarter 2025 by 4.94 % year on year. The revenue growth was below Alcon Inc 's competitors' average revenue growth of 6.67 %, achieved in the same quarter.
Alcon inc Net Income in the 4 quarter 2025 fell year on year by -3.73%, while most of its competitors have experienced a contraction in net income by -41.92 %.
Alcon Inc 's Comment on Competition and Industry Peers
Alcon operates in the medical device and healthcare industry, competing with companies that may introduce similar products and marketing strategies. For compensation benchmarking and competitive positioning, Alcon uses a peer group comprising international and U.S. companies of comparable size, industry, business mix, and global presence. The 2025 peer group includes Agilent Technologies Inc., Align Technology Inc., Bausch Health Companies Inc., Baxter International Inc., Becton Dickinson & Company, Biogen Inc., Boston Scientific, Dentsply Sirona Inc., Edwards Lifesciences Corporation, EssilorLuxottica, Fresenius Medical Care, and Givaudan. Alcon's revenue and market capitalization exceed the median of this group. The company faces challenges such as pricing pressure, industry consolidation, and the necessity to educate healthcare providers to recommend its products.
Overall company revenue, grew less, than total company revenues, at 4.94 % and company approximately market share, declined to 19.25 %. << More on ALC Market Share.
*Market share is calculated based on total revenue.
Escalon Medical Corp is a medical technology company that operates through three segments: ophthalmic diagnostics, ophthalmic surgical and ambulance services. They develop, manufacture and sell a range of medical devices and provide EMS billing services to healthcare providers.
National Vision Holdings Inc is a leading retailer of eyewear and optical products in the United States. The company operates a vertically integrated business model, which involves manufacturing, marketing, and distributing a wide range of eyewear products through its branded retail stores and third-party retail locations. National Vision Holdings Inc focuses on offering affordable and accessible vision care solutions to customers by leveraging its supply chain and retail network capabilities.
Glaukos Corp is a medical technology company that specializes in developing and commercializing ophthalmic treatment solutions. Their business model revolves around providing innovative products for the surgical treatment of glaucoma and other eye disorders. Through research, development, and partnerships, Glaukos aims to improve patient outcomes by offering minimally invasive, cost-effective treatments.
Sources:
Alcon inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Alcon inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
